Dexcom Inc. - BDR logo

Dexcom Inc. - BDR (D1EX34)

Market Closed
10 Aug, 19:55
B3 B3
R$
8. 98
+0.35
+4.0556%
R$
138.34B Market Cap
134.71 P/E Ratio
- Div Yield
170 Volume
1.43 Eps
R$ 8.63
Previous Close
Add Transaction
Day Range
8.65 9
Year Range
5.75 9
Want to track D1EX34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Dexcom Inc. - BDR (D1EX34) Statistics

Valuation metrics

Market Cap 138.34B
Enterprise value 778.03B
Trailing P/E (ttm) 32.92
Forward P/E -
PEG ratio 0.36
Price/Sales (ttm) 31.64
Price/Book (mrq) 10.09
Enterprise Value/Revenue 31.58
Enterprise Value/EBITDA 117.74

Overview

Shares outstanding 385.9M
Float 19.23B
Shares short -
% Held by insiders -
% Held by institutions 0%
Average volume (10 days) 3.08K
Average volume (90 days) 1.27K

Price summary

52-Week low 5.75
52-Week high 9
Beta 1.45
50-Day moving average 7.14
200-Day moving average 7.04

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 4:1
Last split Date 13 Jun 2022

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin 0.19%
Operating margin 0.21%

Operational effectiveness

Return on assets 0.1%
Return on equity 0.36%

Income Statement

Revenue (ttm) 24.63B
Revenue per share (ttm) 0.25
Quarterly revenue growth (yoy) 0.15%
Gross profit (ttm) 15.15B
EBITDA 1.48B
Net income to common (ttm) 4.76B
Diluted EPS (ttm) 0.24
Quarterly earnings growth (yoy) 0.89%

Balance Sheet

Total cash (mrq) 12.35B
Total cash per share (mrq) 0.12
Total debt (mrq) 7.08B
Total Debt/Equity (mrq) 46.83
Current ratio (mrq) 1.95%
Book value per share (mrq) 0.78

Cash Flow

Cash flow statement 9.11B
Levered free cash flow (LFCF) 5.4B